Drugmaker GSK Buys US Firm Focused On Gastro Cancer
British pharmaceutical company GSK on Monday said it had agreed to buy a US company that specialises in the treatment of rare gastrointestinal cancer GIST.
GSK said in a statement that it had agreed to acquire Boston-based IDRx for up to…